SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (10686)7/8/1999 5:52:00 PM
From: Minos  Read Replies (2) | Respond to of 17367
 
Hey all,

Is this move for real, or was it an extension of general Biotech euphoria. BGEN earnings. HGSI and Elan Pharmaceutical all with exciting news and all? Are the mo mos piling on? With all due respect to the science, what do you guys think will happen to the share price in the coming days? I would expect a pullback, no?

-Minos



To: Arthur Radley who wrote (10686)7/8/1999 6:05:00 PM
From: aknahow  Respond to of 17367
 
The Allergan payments should hit this quarter but the "premium" should hit only after the shares are issued and I think that will be next quarter. Jumping the gun a bit with my post but since I have complained about this type of earnings elsewhere I did not want to overlook it here.



To: Arthur Radley who wrote (10686)7/8/1999 7:43:00 PM
From: aknahow  Respond to of 17367
 
Think I-Prex, anti-angiogenesis! But it's not.

news.bbc.co.uk


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News